Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 6 March

Bell Direct
March 6, 2025

Morning Bell 5 March

Bell Direct
March 5, 2025

Morning Bell 4 March

Grady Wulff
March 4, 2025

Morning Bell 3 March

Bell Direct
March 3, 2025

Weekly Wrap 28 February

Bell Direct
February 28, 2025

Morning Bell 27 February

Bell Direct
February 27, 2025

Morning Bell 26 February

Bell Direct
February 26, 2025

Morning Bell 25 February

Bell Direct
February 25, 2025

Morning Bell 24 February

Bell Direct
February 24, 2025

Weekly Wrap 21 February

Bell Direct
February 21, 2025

Morning Bell 20 February

Bell Direct
February 20, 2025